---
title: "Leqvio (inclisiran) in hypercholesterolemia: Dosing and administration questions"
description: "Dosing and administration questions on Leqvio (inclisiran) in hypercholesterolemia, each answered with verbatim quotes from the manufacturer's US website for healthcare professionals or documents it links. Topics: Treatment combinations. Questions: Can Leqvio be used with or without a statin? 1 question quoted from 2 sources."
canonical: "https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/dosing-and-administration"
published: "2026-11-14T00:11:41-05:00"
modified: "2026-11-14T01:54:55-05:00"
---

# Leqvio (inclisiran) in hypercholesterolemia: Dosing and administration questions

Manufacturer: Novartis Pharmaceuticals Corporation  
Prescribing information: [Leqvio](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf)

Dosing and administration questions that apply to every indication of Leqvio are on [Leqvio (inclisiran), all indications: Dosing and administration](https://www.evicenter.com/medical-information/leqvio/dosing-and-administration).

## Treatment combinations

<a id="leqvio-with-statin"></a>

### Can Leqvio be used with or without a statin?

> “Can be taken with or without a statin—no requirement to titrate up to get to maximum tolerability before adding LEQVIO<sup>1</sup>”

Source: [LEQVIO: Dosing & Administration | LEQVIO® (inclisiran) | HCP, captured 2026-11-14](https://www.leqviohcp.com/dosing-and-administration#:~:text=Can%20be%20taken%20with%20or,to%20maximum%20tolerability%20before%20adding)

> “The efficacy of LEQVIO was investigated in three randomized, double-blind, placebo-controlled trials that 
> enrolled 3,660 adults with HeFH, clinical ASCVD, or increased risk for ASCVD, who were taking maximally 
> tolerated statin therapy and who required additional LDL-C lowering.”

Source: [LEQVIO: Prescribing information, page 9, captured 2026-11-14](https://www.novartis.com/us-en/sites/novartis_us/files/leqvio.pdf#page=9)

Note: The Prescribing Information passage describes the adult trials, in which patients were taking maximally tolerated statin therapy; the statement about use without a statin is the HCP site's.

## Related pages
- [Medical information: Leqvio (inclisiran): Hypercholesterolemia](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia)
- [Indication](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/indication)
- [Clinical trials](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/clinical-trials)
- [Safety](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/safety)
- [Specific populations](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/specific-populations)
- [Guidelines](https://www.evicenter.com/medical-information/leqvio--hypercholesterolemia/guidelines)
